On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
On Mar. 24, 2020, three Oxford University-based COVID-19 projects were among the first to benefit from a share…
On Mar. 24, 2020, Dynavax Technologies and Clover Biopharmaceuticals, a China-based global clinical-stage biotechnology company, announced a research…
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
On Mar. 24, 2020, Ology Bioservices and Inovio Pharma announced the Department of Defense (DOD) has awarded Ology…
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
On Mar. 19, 2020, Clinical pathologists, infectious disease physicians and scientists at the UC Davis Medical Center, California…
On Mar. 18, 2020, StartX, a non-profit startup community of more than 1500 Stanford faculty and alumni founders,…
On Mar. 18, 2020, Entos Pharmaceuticals, a health-care biotechnology company that develops new therapeutic compounds using the company’s…
On Mar. 18, 2020, Immunology researchers at the University of Miami Miller School of Medicine announced a collaboration…
On Mar. 18, 2020, Emergent BioSolutions announced an agreement with Vaxart, whereby Emergent has agreed to utilize its…
On Mar. 18, 2020, Nike CEO John Donahoe and his wife, Eileen, along with Nike Chairman Mark Parker…
On Mar. 17, 2020, CanSino Biologics announced that its recombinant novel Coronavirus Vaccine (Adenovirus Type 5 Vector) candidate…
On Mar. 17, 2020, Innovation Pharma announced details on the Material Transfer Agreement signed with a leading public…
On Mar. 17, 2020, Pfizer and BioNTech announced the companies have agreed to a letter of intent regarding…
On Mar. 16, 2020, the National Institutes of Health (NIH announced that a Phase 1 clinical trial evaluating…
On Mar. 16, 2020, Moderna announced that the first participant had been dosed in the Phase 1 study…
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…
On Mar. 13, 2020, declared a COVID-related emergency under Section 501(b) of the Stafford Act [18]. Under the…
On Mar. 13, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical Companies have entered a collaboration with…
On Mar. 12, 2020, Predictive Oncology announced it will launch a new AI platform for vaccine and drug…
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
On Mar. 10, 2020, the Bill & Melinda Gates Foundation, Wellcome, and Mastercard committed up to $125 million…